Hepatocyte growth factora new marker for prognosis in acute coronary syndrome

Growth Factors

Volumn 28, Issue 2, 2010, Pages 75-81

  Konopka, Anna ^a   Janas, Jadwiga ^a   Piotrowski, Walerian ^a   Stȩpińska, Janina ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

ACS; Biomarkers; HGF; Myocardial infarction; Risk stratification

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; SCATTER FACTOR; TROPONIN I; HGF PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE NECROSIS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; AGED; ANGIOCARDIOGRAPHY; BLOOD; CLINICAL TRIAL; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT;

EID: 77949443559     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903403984     Document Type: Article

References (27)

1. Anderson JL, Adams CD, Antman EM, Bridges ChR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS and ACC/AHA Task Force Members. 2007. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction). Circulation 116:e148-e304.
2. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, Mc Cabe CH, Cannon ChP, Fischer GA, Fung AY, Thompson Ch, Wybenga D, Braunwald E. 1996. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndrome. N Engl J Med 335:1342-1349.
3. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany ChJ, Pearle DL, Sloan MA, Smith SC and 2004 Writing Committee Members. 2008. 2007 Focused update of the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with STelevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation 117:296-329.
4. Bassand J-P, Hamm ChW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KAA, Hasdai D, Ohman EM, Wallentin L, Wijns W and ESC Committee for Practice Guidelines. 2007. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 28:1598-1660.
5. Blanquaert F, Delany AM, Canalis E. 1999. Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts. Endocrinology 140:1069-1074.
6. Bottaro D, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804.
7. Cannon Ch, Wintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann F-J, Robertson DH, DeLuca PT, DiBattiste PM, Gibson M, Braunwald E for the TACTICS - Thrombolysis in Myocardial Infarction 18 Investigators. 2001. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/ IIIa inhibitor tirofiban. N Engl J Med 344:1879-1887.
8. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall CH, Cannon ChP, Braunwald E. 2001. The prognostic value of B-natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345:1014-1021.
9. Funakoshi H, Nakamura T. 2003. Hepatocyte growth factor: from diagnosis to clinical applications. Cinica Chimica Acta 327: 1-23.
10. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L. 2003. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation 108: 275-281.
11. Lindhal B, Diderholm E, Lagerqvist B, Venge P,Wallentin L and the FRISC II Investigators. 2001. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: A FRISC II substudy. J Am Coll Cardiol 38:979-986.
12. Luetteke NC, Michalopoulos GK. 1985. Partial purification and characterization of hepatocyte growth factor produced by rat hepatocellular carcinoma cells. Cancer Res 45:6331-6337.
13. Matsumori A, Furukawa Y, Hashimoto T, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Sasayama S. 1996. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 221: 391-395.
14. Matsumoto K, Nakamura T. 1996. Heparin functions as a hepatrophic factor by inducing production of hepatocyte growth factor. Biochem Biophys Res Commun 227:455-461.
15. Matsumoto-Taniura N, Matsumoto K, Nakamura T. 1999. Prostaglandin production in mouse mammary tumor cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts. Br J Cancer 81:194-202.
16. Nakamura T, Nawa K, Ichihara A. 1984. Partial purification and characterization of heptocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450-1459.
17. Nakamura T, Teramoto H, Ichihara A. 1986. Purification and characterization of growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83:6489-6493.
18. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T. 1997. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313.
19. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T. 2000. Myocardial protection from ischemia/ reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106:1511-1519.
20. Pepine CJ. 2000. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes. Am J Cardiol 86(suppl):27M-35M.
21. Sato T, Yoshinouchi T, Sugimoto T, Sakamoto T, Fujieda H, Sato H, Murao S, Kobayashi H, Ohe T. 1998. Significance of hepatocyte growth factor measurement in patients with acute myocardial infarction. J Cardiol 32:77-82.
22. Shimomura T, Ochiai M, Kondo J, Morimoto Y. 1992. A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 8:219-229.
23. Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H, Tominaga T. 1998. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin Cancer Res 4:659-664.
24. Tygesen K, Alpert JS, White HD on behalf of the Joint ESC/ACCF/ AHA/WHF Task Force for the Redefinition of Myocardial Infarction. 2007. Universal definition of myocardial infarction. Eur Heart J 28:2525-2538.
25. Van de Verf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F,Weidinger F,WeisMand ESC Committee for Practice Guidelines (CPG). 2008. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 29:2909-2945.
26. Yasuda S, Goto Y, Baba T, Satoh T, Sumida H, Miyazaki S, Nonogi H. 2000. Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less sever ventricular enlargement and improved cardiac function. J Am Coll Cardiol 36:115-121.
27. Zarnegar R, Michalopoulos GK. 1995. The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 129:1177-1180.